Literature DB >> 12781605

What is the prevalence of hypertrophic scarring following burns?

Kristine M Bombaro1, Loren H Engrav, Gretchen J Carrougher, Shelly A Wiechman, Lee Faucher, Beth A Costa, David M Heimbach, Frederick P Rivara, Shari Honari.   

Abstract

Hypertrophic scarring after burns remains a major problem and is considered to be "common". Pressure garments are commonly used as treatment even though there is little sound data that they reduce the prevalence or magnitude of the scarring. In 1999 we began a study of the efficacy of pressure garments on forearm burns. After studying 30 patients, mainly white adults, we found no hypertrophic scar in either those treated with pressure or without. This prompted us to review the literature on the prevalence of hypertrophic scarring after burns and found only four articles with a relatively small number of patients and only three geographical locations. It became clear that the prevalence of hypertrophic scarring is really unknown. We then did a retrospective study of 110 burn survivors and counted all hypertrophic scars of all sizes and locations in all races and found the prevalence hypertrophic scarring to be 67% which conflicts with the published reports and our prospective study and suggests that further research is necessary. We concluded that a worldwide, prospective survey is necessary to establish the prevalence of hypertrophic scarring after burns. In this article we are calling for and offering to organize this survey.

Entities:  

Mesh:

Year:  2003        PMID: 12781605     DOI: 10.1016/s0305-4179(03)00067-6

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  58 in total

1.  A polarized multispectral imaging system for quantitative assessment of hypertrophic scars.

Authors:  Pejhman Ghassemi; Taryn E Travis; Lauren T Moffatt; Jeffrey W Shupp; Jessica C Ramella-Roman
Journal:  Biomed Opt Express       Date:  2014-09-02       Impact factor: 3.732

2.  The cost of post-burn scarring.

Authors:  U Mirastschijski; J T Sander; U Zier; H O Rennekampff; B Weyand; P M Vogt
Journal:  Ann Burns Fire Disasters       Date:  2015-09-30

Review 3.  Up-to-date approach to manage keloids and hypertrophic scars: a useful guide.

Authors:  Anna I Arno; Gerd G Gauglitz; Juan P Barret; Marc G Jeschke
Journal:  Burns       Date:  2014-04-24       Impact factor: 2.744

Review 4.  [Therapy of hypertrophic scars and keloids].

Authors:  R Aschoff
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

Review 5.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

6.  Dyspigmented hypertrophic scars: Beyond skin color.

Authors:  Abdulnaser Alkhalil; Bonnie C Carney; Taryn E Travis; Seid Muhie; Stacy Ann Miller; Jessica C Ramella-Roman; Pehman Ghassemi; Rasha Hammamieh; Marti Jett; Lauren T Moffatt; Jeffrey W Shupp
Journal:  Pigment Cell Melanoma Res       Date:  2019-04-05       Impact factor: 4.693

Review 7.  Hypertrophic scarring: the greatest unmet challenge after burn injury.

Authors:  Celeste C Finnerty; Marc G Jeschke; Ludwik K Branski; Juan P Barret; Peter Dziewulski; David N Herndon
Journal:  Lancet       Date:  2016-10-01       Impact factor: 79.321

8.  Hypertrophic Scars: Are Vitamins and Inflammatory Biomarkers Related with the Pathophysiology of Wound Healing?

Authors:  Inês Correia-Sá; Paula Serrão; Marisa Marques; Maria A Vieira-Coelho
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

9.  A microarray analysis of temporal gene expression profiles in thermally injured human skin.

Authors:  J A Greco; A C Pollins; B E Boone; S E Levy; L B Nanney
Journal:  Burns       Date:  2009-09-24       Impact factor: 2.744

Review 10.  Biology and principles of scar management and burn reconstruction.

Authors:  Edward E Tredget; Benjamin Levi; Matthias B Donelan
Journal:  Surg Clin North Am       Date:  2014-08       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.